Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell fate acquisition and reprogramming by the proneural transcription factor ASCL1. | Open Biol | 2025 | 40527452 | PubTator, text mining | PubMed |
| ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer. | Mol Med | 2025 | 40500731 | PubTator, text mining | PubMed |
| Distinct proliferative and neuronal programmes of chromatin binding and gene activation by ASCL1 are cell cycle stage-specific. | Development | 2025 | 40452575 | PubTator, text mining | PubMed |
| FOXA2 promotes metastatic competence in small cell lung cancer. | Nat Commun | 2025 | 40419484 | PubTator, text mining | PubMed |
| A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas. | J Vis Exp | 2025 | 40418677 | PubTator, text mining | PubMed |
| Molecular subtyping dictates therapeutic response to anti-PD-L1 immunotherapy in ES-SCLC. | Cancer Immunol Immunother | 2025 | 40402312 | PubTator, text mining | PubMed |
| Insights into growth retardation and dwarfism caused by goose parvovirus in goslings: a transcriptomic profiling study. | Front Vet Sci | 2025 | 40395806 | PubTator, text mining | PubMed |
| Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature. | Transl Lung Cancer Res | 2025 | 40386726 | PubTator, text mining | PubMed |
| Effect of the number of induction chemotherapy cycles on the efficacy of first-line atezolizumab combined with chemotherapy in extensive-stage small cell lung cancer. | Transl Lung Cancer Res | 2025 | 40386714 | PubTator, text mining | PubMed |
| Molecular mechanisms and therapeutic strategies for small‑cell lung cancer transformation after TKI therapy in EGFR‑mutated lung adenocarcinoma (Review). | Mol Clin Oncol | 2025 | 40384936 | PubTator, text mining | PubMed |
| Dissecting small cell carcinoma of the esophagus ecosystem by single-cell transcriptomic analysis. | Mol Cancer | 2025 | 40375239 | PubTator, text mining | PubMed |
| Blood-Brain Barrier (BBB) Dysfunction in CNS Diseases: Paying Attention to Pericytes. | CNS Neurosci Ther | 2025 | 40371544 | PubTator, text mining | PubMed |
| Epstein-Barr virus-positive small cell neuroendocrine carcinoma of the nasopharynx: A clinicopathologic study of 7 cases and literature review. | Hum Pathol | 2025 | 40354885 | PubTator, text mining | PubMed |
| Molecular Subtypes and Targeted Therapeutic Strategies in Small Cell Lung Cancer: Advances, Challenges, and Future Perspectives. | Molecules | 2025 | 40333678 | PubTator, text mining | PubMed |
| Multi-Omics Integration Analysis Revealed That miR-375-3p Is a Two-Sided Factor Regulating the Development and TUMORIGENESIS of Alzheimer's Disease. | Int J Mol Sci | 2025 | 40332288 | PubTator, text mining | PubMed |
| Polygraph: a software framework for the systematic assessment of synthetic regulatory DNA elements. | Genome Biol | 2025 | 40329378 | PubTator, text mining | PubMed |
| Functional characterization of the ATOH1 molecular subtype indicates a pro-metastatic role in small cell lung cancer. | Cell Rep | 2025 | 40305287 | PubTator, text mining | PubMed |
| Extracellular Vesicular Delta-Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis. | Adv Sci (Weinh) | 2025 | 40285610 | PubTator, text mining | PubMed |
| Clinicopathological characteristics of transcription factor-defined subtypes in bladder small cell carcinoma. | BMC Cancer | 2025 | 40275187 | PubTator, text mining | PubMed |
| Identifying reproducible transcription regulator coexpression patterns with single cell transcriptomics. | PLoS Comput Biol | 2025 | 40257984 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=12